Search information about vibegron

Are you interested in learning about vibegron for the treatment of overactive bladder (OAB)? To continue, please complete all required (*) fields below.

I understand that the information collected pertaining to me will be used in accordance with Urovant Sciences' Privacy Statement. By submitting this form, I agree that any information I request is unsolicited.*

Related Information

Report Adverse Events

833-UROVANT (Option 1)

Report Product Complaints

833-UROVANT (Option 1)

Tell us what interests you

How interested are you in learning more about the following topics?

The hypothetical role of targeted gene therapy in modulating BK channel expression
The role of beta-3 adrenergic receptor agonists in the treatment of patients with OAB
A comprehensive treatment overview for OAB
Treatment approaches in OAB
Recent publications on vibegron and OAB


We’ve received your completed survey. Thanks for participating.


Thank You.

We’ve received your inquiry. Thank you for contacting Urovant Sciences Medical Affairs. We will contact you shortly.


Take Survey

Welcome to
Urovant Sciences Medical Affairs

This site is intended as an educational resource for U.S. healthcare providers. The content may include information about products or potential uses that have not been approved by the U.S. Food and Drug Administration.

This information is not intended to be promotional or deliver medical advice.

Choose an option:

I’m a U.S. healthcare professional I’m a U.S. patient or caregiver